Lutathera CA 370 MBq/ml, Infusionslösung

7680665800028 CH-66580 Infusionslösung
Lutathera CA 370 MBq/ml, Infusionslösung
Lutathera CA 370 MBq/ml, Infusionslösung
Lutathera CA 370 MBq/ml, Infusionslösung
1 / 3
google

Article details

Package size
20.5 - 25
Selling units
20
Measure
ml
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/12/2024
Summary of Product Characteristics
Français
13/12/2024
Summary of Product Characteristics
Italien
13/12/2024

Detailed composition

Substance Quantity Type Category
(N/A)
370.0 MBQ Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance ANTON
(N/A)
- Substance HNIDK
(N/A)
3.24 MG Substance HBESI

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
66580
Drug name
Lutathera CA, Infusionslösung
Galenic form
LSPA
ATC Code
V10XX04
Authorization status
Z
Dispensing category
A
First authorization
25/06/2019
Authorization expiration date
31/12/9999
IT Number
17.02.
Domain
Human medicine
Field of application
gastroenteropankreatische neuroendokrine Tumore (GEP‑NET)

Package details

Description (FR)
LUTATHERA CA sol perf 370 MBq/ml flac
Description (DE)
LUTATHERA CA Inf Lös 370 MBq/ml Durchstf
Market launch
25/06/2019
Narcotic (BTM)
No

Other package sizes (1)

LUTATHERA sol perf 370 MBq/ml (#) fl
None None
GTIN: 7680665800011
Not in V1